Draw/line
Home / Compare / Sermorelin vs Tesamorelin

Sermorelin vs Tesamorelin

Both prompt the pituitary gland to release growth hormone. One is an approved drug with a single narrow use; the other was approved, discontinued and is now compounded.

Side-by-side facts · No recommendation · Reviewed

SermorelinTesamorelinSame for both

SermorelinTesamorelin
What it isFragment of growth-hormone-releasing hormoneGrowth-hormone-releasing hormone analog
Status todayNo approved product on the market; compounded on prescriptionFDA-approved (Egrifta) for one use
Approved useWas approved in 1997 for growth hormone deficiency in children (discontinued 2008)Reducing excess abdominal fat in people with HIV who have lipodystrophy
CompoundingCompounded by pharmaciesNot eligible: FDA treats it as a biological product
EvidencePediatric data from its approved years; limited data for adult uses promoted todayTwo placebo-controlled trials in 816 adults with HIV

Key differences

Tesamorelin is an approved drug, but only for abdominal fat in people with HIV-associated lipodystrophy. It is not approved for general weight loss.

Sermorelin was approved as Geref in 1997 and discontinued by its maker in 2008. FDA later confirmed the withdrawal was not for safety or effectiveness reasons. Today it is obtained through compounding pharmacies, so quality depends on the pharmacy.

Side effects

For tesamorelin, joint pain, injection-site reactions, stomach pain, swelling and muscle pain were the most common, and blood sugar control worsened more often than with placebo.

Questions

Is sermorelin the same as tesamorelin?

No. Both act on the same pathway, but they are different molecules with different regulatory histories.

Is sermorelin FDA approved?

Not today. It was approved in 1997 and discontinued in 2008. It is now compounded on prescription.

Which compound, if any, suits a person is a decision for them and a licensed prescriber. This page compares published facts and does not recommend either.

Sources: Portrait: is sermorelin FDA approved; News-Medical: Egrifta FDA approval; Portrait: sermorelin and tesamorelin FDA records.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.